CochraneDatabaseofSystematicReviews2018,Issue3.Art.No.:CD008980.
DOI: 10.1002/14651858.CD008980.pub3
Cochrane PEC PEARLS 
![]() |
Sébastien Béroud Patricia Jabre |
Cochrane PEC Corner 
![]() |
|
Cochrane PEC
![]()
|
photo |
Cochrane PEC media
Diaporama ppt
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation